Catalyst Wire Dossier Catalyst Wire Dossier

NRL972

NRL972 · Norgine
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for NRL972, covering 2009-03-06 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]

See pricing